Thermo Fisher Scientific Inc.
TMO
$605.00
$5.310.89%
NYSE
| 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.23% | 5.36% | 3.91% | 3.22% | 2.04% |
| Total Other Revenue | -100.00% | -- | -- | -- | -- |
| Total Revenue | 7.23% | 5.36% | 3.91% | 3.22% | 2.05% |
| Cost of Revenue | 7.80% | 6.26% | 4.47% | 2.33% | 1.33% |
| Gross Profit | 6.42% | 4.08% | 3.12% | 4.52% | 3.08% |
| SG&A Expenses | 3.96% | 1.20% | -0.84% | -0.58% | -0.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -546.67% | -546.67% | -550.00% | 2,900.00% | 2,900.00% |
| Total Operating Expenses | 6.06% | 4.28% | 2.54% | 1.82% | 1.23% |
| Operating Income | 12.40% | 10.18% | 10.15% | 9.81% | 5.79% |
| Income Before Tax | 8.05% | 5.68% | 3.86% | 5.26% | 3.51% |
| Income Tax Expenses | 36.93% | 10.59% | -16.87% | -15.13% | -26.72% |
| Earnings from Continuing Operations | 6.14% | 5.32% | 6.01% | 7.40% | 6.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -350.00% | -325.00% | -135.71% | -100.00% |
| Net Income | 5.82% | 5.11% | 5.81% | 7.07% | 5.84% |
| EBIT | 12.40% | 10.18% | 10.15% | 9.81% | 5.79% |
| EBITDA | 9.74% | 5.92% | 4.31% | 3.10% | 0.10% |
| EPS Basic | 7.47% | 6.54% | 7.09% | 8.26% | 7.03% |
| Normalized Basic EPS | 11.68% | 10.59% | 10.00% | 11.10% | 6.93% |
| EPS Diluted | 7.61% | 6.75% | 7.39% | 8.51% | 7.24% |
| Normalized Diluted EPS | 11.82% | 10.80% | 10.27% | 11.38% | 7.07% |
| Average Basic Shares Outstanding | -1.51% | -1.31% | -1.18% | -1.11% | -1.11% |
| Average Diluted Shares Outstanding | -1.64% | -1.50% | -1.43% | -1.36% | -1.23% |
| Dividend Per Share | 9.76% | 10.00% | 10.26% | 10.53% | 10.81% |
| Payout Ratio | 0.03% | 0.03% | 0.03% | 0.02% | 0.04% |